
Autologous Skin Graft
Patient cells can be captured a day before surgery and used to generate an autologous skin graft like gelatinous substance that reduces probability of rejection, and allows the patient to heal quickly. In addition to improving patient outcome and satisfaction through this new product, it also reduces office liability for infection for the cases where closing the skin is not feasible or very difficult, such as Mohs procedures involving ear, nose, or eye area.



